<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Publications - Sharma Lab</title>
  <link rel="stylesheet" href="styles.css">
</head>
<body>
  <header>
    <h1>Ajay Kumar Sharma Lab</h1>
    <nav>
      <ul>
        <li><a href="index.html">Home</a></li>
        <li><a href="research.html">Research</a></li>
        <li><a href="team.html">Team</a></li>
        <li><a href="publications.html" class="active">Publications</a></li>
        <li><a href="news.html">News</a></li>
        <li><a href="gallery.html">Gallery</a></li>
        <li><a href="contact.html">Contact</a></li>
      </ul>
    </nav>
  </header>

  <main>
    <section>
      <h2>Publications</h2>
      
      <div class="publication-stats">
        <div class="stat-item">
          <h3>Research Impact</h3>
          <p><strong>ORCID:</strong> <a href="https://orcid.org/0000-0003-1361-6923" target="_blank">0000-0003-1361-6923</a></p>
          <p><strong>Google Scholar:</strong> <a href="https://scholar.google.com/citations?user=YOUR_ID" target="_blank">View Profile</a></p>
          <p><strong>Total Publications:</strong> 10+ peer-reviewed articles</p>
          <p><strong>Research Areas:</strong> Radiopharmaceutical Development, PET Imaging, Cancer Theranostics, Medicinal Chemistry</p>
        </div>
      </div>

      <h3>Original Research Articles</h3>
      <div class="publications-list">
        
        <div class="publication-item">
          <h4>2025</h4>
          <ol>
            <li>
              <strong>Sharma, A. K.</strong>, Gupta, K., Mishra, A., Lofland, G., Chen, S. Y., Armstrong, T. M., Zheng, L., Gabrielson, E., Jaffee, E. M., Nimmagadda, S. (2025). "An EphA2-targeted alpha particle theranostic for enhancing PDAC treatment." 
              <em>Theranostics</em>, 15, 4229-4246.
            </li>
          </ol>
        </div>

        <div class="publication-item">
          <h4>2024</h4>
          <ol>
            <li>
              <strong>Sharma, A. K.</strong>, Gupta, K., Mishra, A., Lofland, G., Marsh, I., Kumar, D., Ghiaur, G., Imus, P., Hobbs, R. F., Gocke, C. B., Nimmagadda, S. (2024). "CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET." 
              <em>Advanced Science</em>, 11, 2308617.
            </li>
            <li>
              Dewan, A., Jain, C., Das, M., Tripathi, A., <strong>Sharma, A. K.</strong>, Singh, H., Malhotra, N., Seshasayee, A. S. N., Chakrapani, H., Singh, A. (2024). "Intracellular peroxynitrite perturbs redox balance, bioenergetics, and Fe–S cluster homeostasis in Mycobacterium tuberculosis." 
              <em>Redox Biology</em>, 75, 103285.
            </li>
            <li>
              Mishra, A., <strong>Sharma, A. K.</strong>, Gupta, K., Banka, D. R., Johnson, B. A., Hoffman-Censits, J., Huang, P., McConkey, D. J., Nimmagadda, S. (2024). "Nectin-4 PET for optimizing Enfortumab Vedotin dose-response in urothelial carcinoma." 
              <em>bioRxiv</em> 2024.12.25.630315. 
              <a href="https://doi.org/10.1101/2024.12.25.630315" target="_blank">[DOI]</a>
            </li>
          </ol>
        </div>

        <div class="publication-item">
          <h4>2023</h4>
          <ol>
            <li>
              Mishra, A., Kumar, D., Gupta, K., Lofland, G., <strong>Sharma, A. K.</strong>, Banka, D. S., Hobbs, R. F., Dannals, R. F., Rowe, S. P., Gabrielson, E., Nimmagadda, S. (2023). "Gallium-68–labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics." 
              <em>Clinical Cancer Research</em>, 29(3), 581–591.
            </li>
            <li>
              Mishra, A., Gupta, K., Kumar, D., Lofland, G., <strong>Sharma, A. K.</strong>, Solnes, L. B., Rowe, S. P., Forde, P. M., Pomper, M. G., Gabrielson, E. W., Nimmagadda, S. (2023). "Non-Invasive PD-L1 Quantification Using [<sup>18</sup>F]DK222-PET Imaging in Cancer Immunotherapy." 
              <em>Journal for ImmunoTherapy of Cancer</em>, 11(10), e007535.
            </li>
          </ol>
        </div>

        <div class="publication-item">
          <h4>2019</h4>
          <ol>
            <li>
              Kelkar, D. S., Ravikumar, G., Mehendale, N., Singh, S., Joshi, A., <strong>Sharma, A. K.</strong>, Mhetre, A., Rajendran, A., Chakrapani, H., Kamat, S. S. (2019). "A Chemical–genetic Screen Identifies ABHD12 as an Oxidized-Phosphatidylserine Lipase." 
              <em>Nature Chemical Biology</em>, 15(2), 169–178.
            </li>
            <li>
              <strong>Sharma, A. K.</strong>, Singh, H., Chakrapani, H. (2019). "Photocontrolled Endogenous Reactive Oxygen Species (ROS) Generation." 
              <em>Chemical Communications</em>, 55(36), 5259-5262.
            </li>
          </ol>
        </div>

        <div class="publication-item">
          <h4>2018</h4>
          <ol>
            <li>
              Kumari, P., Kulkarni, A., <strong>Sharma, A. K.</strong>, Chakrapani, H. (2018). "Visible-Light Controlled Release of a Fluoroquinolone Antibiotic for Antimicrobial Photopharmacology." 
              <em>ACS Omega</em>, 3(2), 2155–2160.
            </li>
            <li>
              Kulkarni, A., <strong>Sharma, A. K.</strong>, Chakrapani, H. (2018). "Redox-Guided Small Molecule Antimycobacterials." 
              <em>IUBMB Life</em>, 70(9), 826–835.
            </li>
          </ol>
        </div>

        <div class="publication-item">
          <h4>2017</h4>
          <ol>
            <li>
              <strong>Sharma, A. K.</strong>, Nair, M., Chauhan, P., Gupta, K., Saini, D. K., Chakrapani, H. (2017). "Visible-Light-Triggered Uncaging of Carbonyl Sulfide for Hydrogen Sulfide (H<sub>2</sub>S) Release." 
              <em>Organic Letters</em>, 19(18), 4822–4825.
            </li>
          </ol>
        </div>
      </div>

      <div class="manuscripts-in-progress">
        <h3>Manuscripts in Preparation</h3>
        <ul>
          <li><strong>Sharma, A. K.</strong>, Singh, H., Chakrapani, H. "Visible Light Stimulated Generation of Reactive Oxygen Species (ROS) Generation." <em>In preparation</em>.</li>
          <li><strong>Sharma, A. K.</strong>, Aswin, P. K., Chakrapani, H. "Green Light Activated Hydrogen sulfide (H<sub>2</sub>S) Generation." <em>In preparation</em>.</li>
        </ul>
      </div>

      <div class="patents-section">
        <h3>Patents</h3>
        <ul>
          <li><strong>December 30, 2024:</strong> Provisional patent application about "<sup>18</sup>F-Fluorine incorporation strategy to generate <sup>18</sup>F-radiometal theranostic pairs" (JHU Reference: D18426)</li>
        </ul>
      </div>

      <div class="conference-presentations">
        <h3>Selected Conference Presentations</h3>
        
        <h4>Oral/Podium Presentations</h4>
        <ul>
          <li><strong>March 28, 2025:</strong> "Nectin-4 PET to Predict Enfortumab Vedotin (EV) Efficacy in Preclinical Bladder Cancer" - Research in Progress meeting, Johns Hopkins School of Medicine</li>
          <li><strong>November 14, 2023:</strong> "Non-Invasive Detection of Multiple Myeloma Using Ga-68 Labelled CD38 Targeting Peptide" - Radiology Research Day 2023 (Highest scored abstract)</li>
          <li><strong>April 26, 2023:</strong> "Non-Invasive Detection of Multiple Myeloma Using Ga-68 Labelled CD38 Targeting Peptide" - Research in Progress meeting, Johns Hopkins School of Medicine</li>
          <li><strong>March 23, 2022:</strong> "EPhA2 Targeted Peptide-Based Ga-68 Labelled PET Tracer for Pancreatic Tumor Imaging" - Research in Progress meeting, Johns Hopkins School of Medicine</li>
        </ul>

        <h4>Poster Presentations</h4>
        <ul>
          <li><strong>April 25-30, 2025:</strong> "Enhancing urothelial carcinoma treatment with nectin-4-PET: A predictor of enfortumab vedotin efficacy" - AACR Annual Meeting 2025, Chicago, IL</li>
          <li><strong>April 09, 2025:</strong> "Development and Evaluation of a Peptide-Based CD38 Radiotheranostic for Multiple Myeloma" - 32nd SKCCC Trainee Research Day 2025</li>
          <li><strong>September 19, 2024:</strong> "EphA2 targeting peptide-based radiotheranostic for pancreatic adenocarcinoma (PDAC)" - 3rd annual Alavi and Bradley Symposium 2024</li>
          <li><strong>April 5-10, 2024:</strong> "Evaluation of CD38 pharmacodynamics in multiple myeloma using PET with a Ga-68 labelled peptide" - AACR Annual Meeting 2024, San Diego, CA</li>
          <li><strong>April 8-13, 2022:</strong> "Imaging pancreatic ductal adenocarcinoma using an EphA2 receptor tyrosine kinase binding <sup>68</sup>Ga-labeled peptide radiotracer" - AACR Annual Meeting 2022, New Orleans, LA (Scholar-in-Training Award)</li>
        </ul>
      </div>

      <div class="awards-recognition">
        <h3>Awards and Recognition</h3>
        <ul>
          <li><strong>April 2025:</strong> Recognized as a rising star in nuclear medicine and molecular imaging through SNMMI's Ones to Watch program</li>
          <li><strong>November 2023:</strong> Highest scored abstract – JHU Radiology Research Day for "Non-Invasive Detection of Multiple Myeloma Using Ga-68 Labelled CD38 Targeting Peptide"</li>
          <li><strong>April 2022:</strong> Scholar-in-Training Award – AACR annual meeting 2022</li>
          <li><strong>April 2021:</strong> Postdoctoral fellow of the month, Department of Radiology, Johns Hopkins University</li>
          <li><strong>May 2019:</strong> Travel award provided by IISER Pune to attend the Indo-Weizmann joint meeting-2019</li>
          <li><strong>July 2014-August 2019:</strong> Full Ph.D. Fellowship, provided by Council of Scientific Research of India (CSIR)</li>
          <li><strong>April 2014:</strong> All India 45th Rank in national eligibility test (NET)-2013, conducted by CSIR-UGC, India</li>
          <li><strong>April 2014:</strong> All India Rank 470th in Graduate Aptitude Test in Engineering (GATE)- 2014</li>
          <li><strong>June 2012:</strong> 2nd Rank in central university common entrance test-2012, conducted by central universities, India</li>
        </ul>
      </div>

      <div class="funding-section">
        <h3>Current Funding</h3>
        
        <h4>Extramural Funding</h4>
        <ul>
          <li><strong>12/01/24-11/30/26:</strong> "Development of EphA2-Targeted Molecular Radiotheranostics for Lung Neuroendocrine Tumors" - ERF/NETRF Nuclear Medicine Pilot Research Grant ($100,000) - Role: PI</li>
          <li><strong>01/01/24-12/31/24:</strong> "Creation of an EphA2-binding radiotherapeutic for targeting ovarian cancer" - HERA Ovarian cancer foundation: Outside-the-box-1 seed grant ($30,000) - Role: PI</li>
        </ul>

        <h4>Intramural Funding</h4>
        <ul>
          <li><strong>07/01/24-06/30/25:</strong> "Developing Albumin-Bound EphA2-Targeted Molecular Radiotherapeutics for Treatment of Colorectal Cancer" - Colorectal Cancer Research Center of Excellence Pilot Award by Johns Hopkins ($50,000) - Role: PI</li>
        </ul>
      </div>

      <div class="professional-activities">
        <h3>Professional Activities</h3>
        
        <h4>Journal Peer Review Activities</h4>
        <p>Active reviewer for multiple prestigious journals including:</p>
        <ul>
          <li>Nature Communications</li>
          <li>European Journal of Nuclear Medicine and Molecular Imaging</li>
          <li>ACS Omega</li>
          <li>Bioorganic Chemistry</li>
          <li>Frontiers in Immunology</li>
          <li>Cancer Imaging</li>
          <li>Current Oncology</li>
          <li>And many others (30+ reviews completed since 2023)</li>
        </ul>

        <h4>Conference Review Activities</h4>
        <ul>
          <li><strong>May 2025-Present:</strong> Reviewer for abstracts of World Molecular Imaging Congress (WMIC)-2025</li>
          <li><strong>April 2024-September 2024:</strong> Reviewer for abstracts of World Molecular Imaging Congress (WMIC)-2024</li>
        </ul>

        <h4>Professional Society Memberships</h4>
        <ul>
          <li><strong>March 2025-Present:</strong> Member of American Chemical Society (ACS)</li>
          <li><strong>January 2025-Present:</strong> Member of Society of Nuclear Medicine and Molecular Imaging (SNMMI)</li>
          <li><strong>February 2022-Present:</strong> Associate member of American Association of Cancer Research (AACR)</li>
        </ul>
      </div>
    </section>
  </main>

  <footer>
    <p>&copy; 2025 Ajay Kumar Sharma Lab, Johns Hopkins University</p>
  </footer>

  <style>
    .publication-stats {
      background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
      padding: 1.5rem;
      border-radius: 8px;
      border: 2px solid #3b82f6;
      margin-bottom: 2rem;
    }

    .stat-item h3 {
      margin-top: 0;
      color: #1e3a8a;
    }

    .publications-list {
      margin-bottom: 2rem;
    }

    .publication-item {
      margin-bottom: 2rem;
      padding: 1.5rem;
      background: #f8fafc;
      border-radius: 8px;
      border-left: 4px solid #3b82f6;
    }

    .publication-item h4 {
      margin-top: 0;
      color: #1e40af;
      font-size: 1.5rem;
      border-bottom: 2px solid #3b82f6;
      padding-bottom: 0.5rem;
      margin-bottom: 1rem;
    }

    .publication-item ol {
      margin-left: 1.5rem;
    }

    .publication-item li {
      margin-bottom: 1rem;
      line-height: 1.6;
    }

    .manuscripts-in-progress,
    .patents-section,
    .conference-presentations,
    .awards-recognition,
    .funding-section,
    .professional-activities {
      background: #f1f5f9;
      padding: 1.5rem;
      border-radius: 8px;
      border-left: 4px solid #10b981;
      margin-bottom: 2rem;
    }

    .patents-section {
      border-left-color: #8b5cf6;
    }

    .conference-presentations {
      border-left-color: #f59e0b;
    }

    .awards-recognition {
      border-left-color: #ef4444;
    }

    .funding-section {
      border-left-color: #10b981;
    }

    .professional-activities {
      border-left-color: #6366f1;
    }

    .manuscripts-in-progress h3,
    .patents-section h3,
    .conference-presentations h3,
    .awards-recognition h3,
    .funding-section h3,
    .professional-activities h3 {
      margin-top: 0;
      color: #1e40af;
    }

    .awards-recognition h3 {
      color: #dc2626;
    }

    .funding-section h4,
    .conference-presentations h4,
    .professional-activities h4 {
      color: #1e40af;
      margin-top: 1.5rem;
      margin-bottom: 1rem;
      font-size: 1.1rem;
    }
  </style>
</body>
</html>